If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Director/PDMR Shareholding

4 Aug 2022 14:30

RNS Number : 9825U
Indivior PLC
04 August 2022
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that on August 3, 2022, it granted a Conditional Award ('Award') over 348,189 Ordinary Shares of US$0.10 each in the Company ('Shares') under the Indivior Long-Term Incentive Plan ('LTIP') to Nina DeLorenzo, Chief Global Impact Officer, a PDMR of the Company.

The vesting of the Award is subject to the Rules of the LTIP and upon continued employment and the achievement of performance conditions. The performance conditions applicable to the Award is based on (1) relative Total Shareholder Return ('TSR') versus the FTSE 250 excluding investment trusts and (2) relative TSR versus the S&P1500 Pharmaceutical and Biotech Index (50% weighting for each measure).

The number of Shares under Award that will vest will depend upon the extent to which the performance conditions have been achieved. The Award is scheduled to vest on March 1, 2025.

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Nina DeLorenzo

2

 

Reason for the notification

 

a)

 

Position/status

PDMR - Chief Global Impact Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Indivior PLC

b)

 

LEI

 

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.10

 

 

GB00BRS65X63

b)

 

Nature of the transaction

Award over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

348,189

d)

 

Aggregated information

 

- Aggregated volume

 

 - Price

 

 

N/A

e)

 

Date of the transaction

August 3, 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUPPRUPPGWC
Date   Source Headline
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20243:54 pmRNSNotice of Results
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20249:15 amRNSHolding(s) in Company
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20249:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 202312:42 pmRNSHolding(s) in Company
22nd Dec 202311:46 amRNSHolding(s) in Company
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 202310:33 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSIndivior Settles Patent Dispute with Actavis
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 202312:36 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20232:06 pmRNSINDV Prevails in Striking Claims in UK Litigation
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20238:51 amRNSTotal Voting Rights
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.